prazosin has been researched along with Cardiovascular Stroke in 55 studies
Prazosin: A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION.
prazosin : A member of the class of piperazines that is piperazine substituted by a furan-2-ylcarbonyl group and a 4-amino-6,7-dimethoxyquinazolin-2-yl group at positions 1 and 4 respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We describe a 71-year-old male patient who developed acute myocardial infarction (AMI) due to a dynamic left ventricular outflow tract obstruction induced by terazosin." | 7.83 | Myocardial infarction induced by oral terazosin in a patient with predisposing structural cardiomyopathy: case report. ( Ferrando-Castagnetto, F; Lluberas, N; Martínez, F; Vidal Margenat, A; Vignolo, G, 2016) |
| "Central hemodynamic parameters were monitored by invasive procedures (pulmonary arterial catheterization), and prazosin kinetics following the administration of a single 5 mg dose were determined in 69 patients with subacute myocardial infarction, complicated by heart failure." | 7.67 | [Prazosin pharmacodynamics and pharmacokinetics in patients with myocardial infarct complicated by heart failure in the subacute period]. ( Gofman, AM; Ol'binskaia, LI; Petrosian, IuR, 1987) |
| "Prazosine and isosorbide dinitrate have been studied in 15 patients with acute myocardial infarction complicated by heart failure." | 7.66 | Peripheral resistances in acute myocardial infarction: the use of prazosine versus isosorbide dinitrate. ( Costa, PP; Croce, G; Fernandes, P; Permutti, B, 1980) |
| "The hemodynamic effects of the new oral vasocilator prazosin were evaluated in 11 patients with congestive failure following myocardial infarction." | 7.66 | Use of oral prazosin hydrochloride in congestive failure following acute myocardial infarction. ( Coma-Canella, I; Jadraque, LM; Lombera, F; Lopez-Sendon, J, 1979) |
| "To elucidate the hemodynamic effects of prazosin, an antihypertensive agent, in congestive heart failure, we studied 10 patients with ischemic cardiomyopathy and severe ventricular dysfunction." | 7.65 | Sustained reduction of cardiac impedance and preload in congestive heart failure with the antihypertensive vasodilator prazosin. ( Awan, NA; Mason, DT; Maxwell, KS; Miller, RR, 1977) |
| "We describe a 71-year-old male patient who developed acute myocardial infarction (AMI) due to a dynamic left ventricular outflow tract obstruction induced by terazosin." | 3.83 | Myocardial infarction induced by oral terazosin in a patient with predisposing structural cardiomyopathy: case report. ( Ferrando-Castagnetto, F; Lluberas, N; Martínez, F; Vidal Margenat, A; Vignolo, G, 2016) |
| "The present study sought to evaluate the effects of the afterload-reducing drugs captopril and prazosin on changes in antioxidants as well as oxidative stress in relation to hemodynamic function in congestive heart failure (CHF) subsequent to myocardial infarction (MI)." | 3.69 | Effects of afterload-reducing drugs on pathogenesis of antioxidant changes and congestive heart failure in rats. ( Khaper, N; Singal, PK, 1997) |
| "[3H]Prazosin binding was determined in arterial segments of Wistar-Kyoto rats (WKY), and of Wistar rats 5 weeks after myocardial infarction (MI) or sham operation (SHAM)." | 3.69 | Alpha 1-adrenoceptor subtypes in rat aorta and mesenteric small arteries are preserved during left ventricular dysfunction post-myocardial infarction. ( DeMey, JG; Janssen, GM; Stassen, FR; Willemsen, MJ, 1997) |
| "The effect of alpha 1-adrenergic blockade with prazosin on myocardial blood flow at rest and during two levels of treadmill exercise was assessed in 16 chronically instrumented dogs 9-14 days after myocardial infarction had been produced by occlusion of the left circumflex coronary artery." | 3.68 | Effect of alpha 1-adrenergic blockade on myocardial blood flow during exercise after myocardial infarction. ( Bache, RJ; Dai, XZ; Herzog, CA, 1991) |
| "The antiarrhythmic and antifibrillatory actions of the alpha 1-adrenoceptor antagonist prazosin were evaluated in conscious dogs 4-7 days after anterior myocardial infarction." | 3.67 | Alpha-adrenergic influences in canine ischemic sudden death: effects of alpha 1-adrenoceptor blockade with prazosin. ( Lucchesi, BR; Lynch, JJ; Montgomery, DG; Wilber, DJ, 1987) |
| "Central hemodynamic parameters were monitored by invasive procedures (pulmonary arterial catheterization), and prazosin kinetics following the administration of a single 5 mg dose were determined in 69 patients with subacute myocardial infarction, complicated by heart failure." | 3.67 | [Prazosin pharmacodynamics and pharmacokinetics in patients with myocardial infarct complicated by heart failure in the subacute period]. ( Gofman, AM; Ol'binskaia, LI; Petrosian, IuR, 1987) |
| "To investigate the possibility of limiting infarct size by decreasing afterload 32 normotensive patients with uncomplicated acute myocardial infarction (AMI) were put on prazosin and compared with 32 control patients." | 3.66 | Limitation of infarct size by decrease of afterload with prazosin. ( Alexandris, AT; Kalogeropoulos, CK; Karlas, EN; Kolettis, MT; Tzannetis, GC, 1983) |
| "Prazosine and isosorbide dinitrate have been studied in 15 patients with acute myocardial infarction complicated by heart failure." | 3.66 | Peripheral resistances in acute myocardial infarction: the use of prazosine versus isosorbide dinitrate. ( Costa, PP; Croce, G; Fernandes, P; Permutti, B, 1980) |
| "The hemodynamic effects of the new oral vasocilator prazosin were evaluated in 11 patients with congestive failure following myocardial infarction." | 3.66 | Use of oral prazosin hydrochloride in congestive failure following acute myocardial infarction. ( Coma-Canella, I; Jadraque, LM; Lombera, F; Lopez-Sendon, J, 1979) |
| "To elucidate the hemodynamic effects of prazosin, an antihypertensive agent, in congestive heart failure, we studied 10 patients with ischemic cardiomyopathy and severe ventricular dysfunction." | 3.65 | Sustained reduction of cardiac impedance and preload in congestive heart failure with the antihypertensive vasodilator prazosin. ( Awan, NA; Mason, DT; Maxwell, KS; Miller, RR, 1977) |
| "Treatment with prazosin for one month also reduced systemic vascular resistance by 8%, renal vascular resistance increased by 20%, and renal blood flow and the percentage of the cardiac output going to the kidney fell by 14% and 26%." | 2.66 | The renal response to neuroendocrine inhibition in chronic heart failure: double-blind comparison of captopril and prazosin. ( Bayliss, J; Canepa-Anson, R; Norell, M; Poole-Wilson, P; Sutton, G, 1986) |
| "Incidences and severity of ventricular arrhythmia during ischemia and early reperfusion significantly decreased in noradrenaline preconditioned group compared with saline-control group." | 1.37 | Noradrenaline protects in vivo rat heart against infarction and ventricular arrhythmias via nitric oxide and reactive oxygen species. ( Alizadeh, AM; Faghihi, M; Imani, A; Niaraki, SS; Sadr, SS, 2011) |
| "Reserpine pretreatment attenuated this protective effect of preconditioning on reperfusion-induced arrhythmias." | 1.30 | The possible role of adrenergic component in ischemic preconditioning. ( Sharma, A; Singh, M, 1997) |
| "Tyramine pretreatment resulted in a smaller infarct size than in untreated controls (AN/AR, 0." | 1.29 | Alpha-adrenoceptor stimulation with exogenous norepinephrine or release of endogenous catecholamines mimics ischemic preconditioning. ( Bankwala, Z; Hale, SL; Kloner, RA, 1994) |
| "Adenosine receptors were blocked with 8-p-sulfophenyl theophylline (10 mg/kg intravenously), alpha 1-adrenergic receptors were selectively blocked with prazosin (0." | 1.29 | Adrenergic activation confers cardioprotection mediated by adenosine, but is not required for ischemic preconditioning. ( Chien, GL; Davis, RF; Haessler, R; Kuzume, K; Van Winkle, DM; Wolff, RA, 1996) |
| "In phentolamine-treated dogs, arterial pressure and heart rate were kept constant to prevent exacerbation of ischemia." | 1.27 | Effect of alpha-adrenergic blockade on arrhythmias induced by acute myocardial ischemia and reperfusion in the dog. ( Bolli, R; Fisher, DJ; Miller, RR; Taylor, AA; Young, JB, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 31 (56.36) | 18.7374 |
| 1990's | 17 (30.91) | 18.2507 |
| 2000's | 2 (3.64) | 29.6817 |
| 2010's | 5 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wahab, NA | 1 |
| Zainudin, S | 1 |
| AbAziz, A | 1 |
| Kamaruddin, NA | 1 |
| Nunez, WR | 1 |
| Ozaki, MR | 1 |
| Vinagre, AM | 1 |
| Collares, EF | 1 |
| Almeida, EA | 1 |
| Lamont, K | 1 |
| Nduhirabandi, F | 1 |
| Adam, T | 1 |
| Thomas, DP | 1 |
| Opie, LH | 2 |
| Lecour, S | 1 |
| Vidal Margenat, A | 1 |
| Ferrando-Castagnetto, F | 1 |
| Martínez, F | 1 |
| Lluberas, N | 1 |
| Vignolo, G | 1 |
| Imani, A | 1 |
| Faghihi, M | 1 |
| Sadr, SS | 1 |
| Niaraki, SS | 1 |
| Alizadeh, AM | 1 |
| Fu, YJ | 1 |
| Shu, H | 1 |
| Miao, CY | 1 |
| Wang, MW | 1 |
| Su, DF | 1 |
| Bolli, R | 1 |
| Fisher, DJ | 1 |
| Taylor, AA | 1 |
| Young, JB | 1 |
| Miller, RR | 3 |
| Chatterjee, K | 2 |
| Parmley, WW | 2 |
| Manno, BV | 1 |
| Iskandrian, AS | 1 |
| Hakki, AH | 1 |
| Kolettis, MT | 1 |
| Karlas, EN | 1 |
| Tzannetis, GC | 1 |
| Kalogeropoulos, CK | 1 |
| Alexandris, AT | 1 |
| Kather, H | 1 |
| Colucci, WS | 1 |
| Wynne, J | 1 |
| Holman, BL | 1 |
| Braunwald, E | 1 |
| Khomenko, VL | 1 |
| Pomerantsev, VP | 1 |
| Vasiuk, IuA | 1 |
| Wagner, GC | 1 |
| Robinson, PH | 1 |
| Seino, Y | 1 |
| Takano, T | 1 |
| Endo, T | 1 |
| Obayashi, K | 1 |
| Hayakawa, H | 1 |
| Vyden, JK | 1 |
| Rose, HB | 1 |
| Kimura, E | 1 |
| Tzivoni, D | 1 |
| Keren, A | 1 |
| Benhorin, J | 1 |
| Gottlieb, S | 1 |
| Atlas, D | 1 |
| Stern, S | 1 |
| Storm-Mathisen, H | 1 |
| Løken, H | 1 |
| Hebnes, K | 1 |
| Rouleau, JL | 1 |
| Benge, W | 1 |
| Hiramatsu, B | 1 |
| Engler, R | 1 |
| Pouleur, H | 1 |
| Link, J | 1 |
| Printz, M | 1 |
| Covell, JW | 1 |
| López-Sendón, J | 2 |
| Coma Canella, I | 1 |
| Trongé, J | 1 |
| Villamayor, RM | 1 |
| Pérez Baliño, N | 1 |
| Riccitelli, MA | 1 |
| Bertolasi, CA | 2 |
| Oliveri, R | 1 |
| Cremades, E | 1 |
| Bazzino, O | 1 |
| Doval, H | 1 |
| Mason, DT | 4 |
| Costa, PP | 1 |
| Permutti, B | 1 |
| Fernandes, P | 1 |
| Croce, G | 1 |
| Billman, GE | 1 |
| Bankwala, Z | 1 |
| Hale, SL | 1 |
| Kloner, RA | 1 |
| Kitakaze, M | 1 |
| Hori, M | 1 |
| Morioka, T | 1 |
| Minamino, T | 1 |
| Takashima, S | 1 |
| Sato, H | 1 |
| Shinozaki, Y | 1 |
| Chujo, M | 1 |
| Mori, H | 1 |
| Inoue, M | 1 |
| Saeki, K | 1 |
| Ogawa, S | 1 |
| Sadanaga, T | 1 |
| Yoh, S | 1 |
| Furuno, I | 1 |
| Nakamura, Y | 1 |
| Haessler, R | 1 |
| Kuzume, K | 2 |
| Wolff, RA | 1 |
| Chien, GL | 1 |
| Davis, RF | 1 |
| Van Winkle, DM | 1 |
| Khaper, N | 1 |
| Singal, PK | 1 |
| Stassen, FR | 1 |
| Willemsen, MJ | 1 |
| Janssen, GM | 1 |
| DeMey, JG | 1 |
| Sharma, A | 2 |
| Singh, M | 2 |
| Fujita, M | 1 |
| Tanaka, T | 1 |
| Nakae, I | 1 |
| Tamaki, S | 1 |
| Kihara, Y | 1 |
| Nohara, R | 1 |
| Sasayama, S | 1 |
| Lloyd, EA | 1 |
| Awan, NA | 2 |
| Coma-Canella, I | 1 |
| Lombera, F | 1 |
| Jadraque, LM | 1 |
| Maxwell, KS | 1 |
| Verma, SP | 1 |
| Silke, B | 1 |
| Reynolds, GW | 1 |
| Kelly, JG | 1 |
| Richmond, A | 1 |
| Taylor, SH | 1 |
| Boutjdir, M | 1 |
| el-Sherif, N | 1 |
| Herzog, CA | 1 |
| Dai, XZ | 1 |
| Bache, RJ | 1 |
| Rowley, KG | 1 |
| Tung, LH | 1 |
| Hodsman, GP | 1 |
| Howes, LG | 1 |
| Jarrott, B | 1 |
| Beart, PM | 1 |
| Louis, WJ | 1 |
| Murdock, CJ | 1 |
| Hickey, GM | 1 |
| Hockings, BE | 1 |
| Pitman, GF | 1 |
| Taylor, RR | 1 |
| Morozova, TE | 2 |
| Petrosian, IuR | 2 |
| Gofman, AM | 2 |
| Itaya, T | 1 |
| Hashimoto, H | 1 |
| Satoh, R | 1 |
| Uematsu, T | 1 |
| Nakashima, M | 1 |
| Wilber, DJ | 1 |
| Lynch, JJ | 1 |
| Montgomery, DG | 1 |
| Lucchesi, BR | 1 |
| Franciosa, JA | 1 |
| Ol'binskaia, LI | 2 |
| Wood, M | 1 |
| Bayliss, J | 1 |
| Canepa-Anson, R | 1 |
| Norell, M | 1 |
| Poole-Wilson, P | 1 |
| Sutton, G | 1 |
6 reviews available for prazosin and Cardiovascular Stroke
| Article | Year |
|---|---|
Right ventricular function: methodologic and clinical considerations in noninvasive scintigraphic assessment.
Topics: Animals; Captopril; Coronary Disease; Echocardiography; Heart; Heart Defects, Congenital; Heart Vent | 1984 |
[Peripheral vasodilator agents in cardiology].
Topics: Clinical Trials as Topic; Coronary Vessels; Heart Failure; Hemodynamics; Humans; Hydralazine; Myocar | 1980 |
Afterload reduction and cardiac performance. Physiologic basis of systemic vasodilators as a new approach in treatment of congestive heart failure.
Topics: Aorta; Cardiac Output; Chronic Disease; Heart; Heart Failure; Heart Ventricles; Hemodynamics; Humans | 1978 |
The use of vasodilator agents in the treatment of heart failure.
Topics: Cardiac Output; Cardiomegaly; Catheterization; Chronic Disease; Coronary Vessels; Dose-Response Rela | 1979 |
Afterload reduction in the management of congestive heart failure following acute myocardial infarction.
Topics: Acute Disease; Dopamine; Heart Failure; Hemodynamics; Humans; Hydralazine; Myocardial Infarction; Ni | 1978 |
Plasma drug binding: implications for anesthesiologists.
Topics: Age Factors; Alfentanil; Alprenolol; Anesthesia; Anesthetics; Blood Proteins; Bupivacaine; Burns; Ca | 1986 |
5 trials available for prazosin and Cardiovascular Stroke
| Article | Year |
|---|---|
Long-term therapy of heart failure with prazosin: a randomized double blind trial.
Topics: Adult; Aged; Cerebrovascular Disorders; Clinical Trials as Topic; Double-Blind Method; Drug Toleranc | 1980 |
[Peripheral vasodilator agents in cardiology].
Topics: Clinical Trials as Topic; Coronary Vessels; Heart Failure; Hemodynamics; Humans; Hydralazine; Myocar | 1980 |
Alterations in left ventricular function and coronary hemodynamics with captopril, hydralazine and prazosin in chronic ischemic heart failure: a comparative study.
Topics: Aged; Captopril; Coronary Disease; Dose-Response Relationship, Drug; Heart Failure; Hemodynamics; Hu | 1982 |
Effect of alpha 1-adrenoceptor blockade on ventricular ectopic beats inacute myocardial infarction.
Topics: Adrenergic alpha-Antagonists; Dose-Response Relationship, Drug; Humans; Male; Middle Aged; Myocardia | 1990 |
The renal response to neuroendocrine inhibition in chronic heart failure: double-blind comparison of captopril and prazosin.
Topics: Aged; Aldosterone; Captopril; Cardiac Output; Cardiomyopathy, Dilated; Coronary Disease; Double-Blin | 1986 |
45 other studies available for prazosin and Cardiovascular Stroke
| Article | Year |
|---|---|
Utility of alpha-blockade in a hypotensive pheochromocytoma patient with myocardial infarction.
Topics: Adrenal Gland Neoplasms; Adrenergic alpha-1 Receptor Antagonists; Adult; Echocardiography; Humans; H | 2015 |
Neural mechanisms and delayed gastric emptying of liquid induced through acute myocardial infarction in rats.
Topics: Adrenergic alpha-1 Receptor Antagonists; Animals; Baclofen; GABA-B Receptor Agonists; Gastric Emptyi | 2015 |
Role of melatonin, melatonin receptors and STAT3 in the cardioprotective effect of chronic and moderate consumption of red wine.
Topics: Animals; Cardiotonic Agents; Male; Melatonin; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardial I | 2015 |
Myocardial infarction induced by oral terazosin in a patient with predisposing structural cardiomyopathy: case report.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Angina Pectoris; Cardiomyopathies; Coronary Angiograp | 2016 |
Noradrenaline protects in vivo rat heart against infarction and ventricular arrhythmias via nitric oxide and reactive oxygen species.
Topics: Adrenergic alpha-Agonists; Animals; Arrhythmias, Cardiac; Cyclic N-Oxides; Ischemic Preconditioning, | 2011 |
Restoration of baroreflex function by ketanserin is not blood pressure dependent in conscious freely moving rats.
Topics: Animals; Antihypertensive Agents; Baroreflex; Blood Pressure; Female; Ketanserin; Male; Myocardial I | 2004 |
Calcium ions, drug action and the heart--with special reference to calcium antagonist drugs.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Animals; Arrhythmias, Cardiac; Calcium; Calcium Channe | 1984 |
Effect of alpha-adrenergic blockade on arrhythmias induced by acute myocardial ischemia and reperfusion in the dog.
Topics: Adrenergic alpha-Antagonists; Animals; Arrhythmias, Cardiac; Blood Pressure; Carbon Dioxide; Coronar | 1984 |
Vasodilator therapy for acute myocardial infarction and chronic congestive heart failure.
Topics: Captopril; Heart Failure; Hemodynamics; Humans; Hydralazine; Myocardial Infarction; Prazosin; Region | 1983 |
Limitation of infarct size by decrease of afterload with prazosin.
Topics: Adult; Aged; Aspartate Aminotransferases; Electrocardiography; Female; Hemodynamics; Humans; L-Lacta | 1983 |
[Hypertensive therapy with prazosin. Concomitant cardiovascular, metabolic and respiratory diseases. Proven facts and potential aspects].
Topics: Adolescent; Adult; Arrhythmias, Cardiac; Cardiovascular Diseases; Diabetes Complications; Humans; Hy | 1984 |
The role of vasodilator therapy in the management of the patient with acute myocardial infarction.
Topics: Heart Failure; Heart Rupture; Hemodynamics; Humans; Hydralazine; Mitral Valve Insufficiency; Myocard | 1981 |
Unloading effects of vasodilators on peripheral circulation and cardiac hemodynamics in patients with acute myocardial infarction.
Topics: Adult; Aged; Female; Heart; Hemodynamics; Humans; Isosorbide Dinitrate; Leg; Male; Middle Aged; Myoc | 1982 |
Prazosin therapy for refractory variant angina.
Topics: Aged; Angina Pectoris, Variant; Coronary Vasospasm; Electrocardiography; Female; Humans; Male; Middl | 1983 |
Complications in long term treatment of essential hypertension.
Topics: Benzothiadiazines; Diuretics; Female; Humans; Hypertension; Male; Methyldopa; Middle Aged; Myocardia | 1981 |
Changes in control of renin release in congestive heart failure in dogs: response to acute and chronic vasodilator therapy.
Topics: Animals; Blood Pressure; Blood Volume; Dogs; Heart Failure; Heart Rate; Hydralazine; Myocardial Infa | 1982 |
[Comparative hemodynamic effect of sodium nitroprusside and prazosin hydrochloride in patients with cardiac insufficiency following acute myocardial infarction].
Topics: Aged; Female; Ferricyanides; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infa | 1981 |
[Vasodilator therapy of pump failure in acute myocardial infarction].
Topics: Adult; Aged; Female; Ferricyanides; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Male; | 1980 |
[Acute myocardial infarction with pump failure: hemodynamic response to prazosin].
Topics: Adult; Aged; Arterioles; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardial | 1980 |
Vasodilator therapy in congestive heart failure.
Topics: Heart Failure; Hemodynamics; Humans; Myocardial Infarction; Prazosin; Quinazolines; Vasodilator Agen | 1981 |
Peripheral resistances in acute myocardial infarction: the use of prazosine versus isosorbide dinitrate.
Topics: Cardiac Output; Hemodynamics; Humans; Isosorbide Dinitrate; Myocardial Infarction; Prazosin; Quinazo | 1980 |
Effect of alpha 1-adrenergic receptor antagonists on susceptibility to malignant arrhythmias: protection from ventricular fibrillation.
Topics: Adrenergic alpha-Antagonists; Animals; Blood Pressure; Dioxanes; Disease Models, Animal; Dogs; Elect | 1994 |
Alpha-adrenoceptor stimulation with exogenous norepinephrine or release of endogenous catecholamines mimics ischemic preconditioning.
Topics: Animals; Blood Pressure; Coronary Circulation; Heart Rate; Male; Myocardial Infarction; Myocardial I | 1994 |
Alpha 1-adrenoceptor activation mediates the infarct size-limiting effect of ischemic preconditioning through augmentation of 5'-nucleotidase activity.
Topics: 5'-Nucleotidase; Adaptation, Biological; Adenosine; Animals; Blood Pressure; Dogs; Endocardium; Esop | 1994 |
Sympathetic denervation of the epicardial border zone in the genesis of dispersion of refractoriness and arrhythmogenesis in a 7-day-old canine myocardial infarction model.
Topics: Animals; Arrhythmias, Cardiac; Dogs; Electric Stimulation; Models, Biological; Myocardial Infarction | 1993 |
Adrenergic activation confers cardioprotection mediated by adenosine, but is not required for ischemic preconditioning.
Topics: Adenosine; Adrenergic alpha-Agonists; Animals; Ischemic Preconditioning, Myocardial; Myocardial Infa | 1996 |
Effects of afterload-reducing drugs on pathogenesis of antioxidant changes and congestive heart failure in rats.
Topics: Animals; Captopril; Catalase; Glutathione Peroxidase; Heart; Heart Failure; Hemodynamics; Lipid Pero | 1997 |
Alpha 1-adrenoceptor subtypes in rat aorta and mesenteric small arteries are preserved during left ventricular dysfunction post-myocardial infarction.
Topics: Adrenergic alpha-Antagonists; Animals; Aorta; Calcium Channel Blockers; Dihydropyridines; In Vitro T | 1997 |
The possible role of adrenergic component in ischemic preconditioning.
Topics: Adrenergic alpha-Antagonists; Adrenergic Uptake Inhibitors; Animals; Blood Pressure; Catecholamines; | 1997 |
Importance of alpha 1-sympathetic activity for diurnal change in ischemic threshold in patients with stable angina.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Amlodipine; Analysis of Variance; Angina Pectoris; Calciu | 1998 |
Possible mechanism of cardioprotective effect of ischaemic preconditioning in isolated rat heart.
Topics: Animals; Colchicine; Creatine Kinase; Female; In Vitro Techniques; Ischemic Preconditioning, Myocard | 2000 |
Use of oral prazosin hydrochloride in congestive failure following acute myocardial infarction.
Topics: Acute Disease; Aged; Blood Pressure; Cardiac Output; Female; Heart Failure; Heart Rate; Humans; Male | 1979 |
Vasodilator and inotropic therapy of heart failure [panel discussion].
Topics: Animals; Cardiac Output; Coronary Circulation; Dobutamine; Dogs; Dose-Response Relationship, Drug; H | 1978 |
Sustained reduction of cardiac impedance and preload in congestive heart failure with the antihypertensive vasodilator prazosin.
Topics: Blood Pressure; Cardiac Output; Female; Heart; Heart Failure; Heart Rate; Hemodynamics; Humans; Male | 1977 |
Vasodilator therapy for acute heart failure: haemodynamic comparison of hydralazine/isosorbide, alpha-adrenoceptor blockade, and angiotensin-converting enzyme inhibition.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Cardiac Output, | 1992 |
Alpha 1-adrenoceptor regulation of delayed afterdepolarizations and triggered activity in subendocardial Purkinje fibers surviving 1 day of myocardial infarction.
Topics: Action Potentials; Adrenergic beta-Agonists; Animals; Dogs; Heart; Myocardial Infarction; Myocardium | 1991 |
Effect of alpha 1-adrenergic blockade on myocardial blood flow during exercise after myocardial infarction.
Topics: Adrenergic alpha-Antagonists; Animals; Coronary Circulation; Dogs; Female; Hemodynamics; Male; Motor | 1991 |
Altered alpha 1-adrenoceptor-mediated responses in atria of rats with chronic left ventricular infarction.
Topics: Animals; Chronic Disease; Female; Heart; Heart Rate; Inositol Phosphates; Male; Myocardial Contracti | 1991 |
[Use of prazosin in the treatment of heart failure in patients with post-infarction cardiosclerosis].
Topics: Adult; Aged; Cardiomyopathy, Dilated; Coronary Artery Disease; Female; Hemodynamics; Humans; Male; M | 1990 |
[Study of the relations between prazosin administration schedule for patients with subacute myocardial infarction and the type of central hemodynamics based on pharmacokinetic data].
Topics: Adult; Aged; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Hemodynamics; H | 1990 |
Increases in alpha-but not beta-adrenoceptors in hypertrophied non-infarcted cardiac muscles from rats with chronic myocardial infarction.
Topics: Animals; Body Weight; Cardiomegaly; Coronary Vessels; Dihydroalprenolol; Male; Muscle Proteins; Myoc | 1990 |
Alpha-adrenergic influences in canine ischemic sudden death: effects of alpha 1-adrenoceptor blockade with prazosin.
Topics: Adrenergic alpha-Antagonists; Animals; Arrhythmias, Cardiac; Dogs; Electrophysiology; Hemodynamics; | 1987 |
Current indications for vasodilator therapy for left ventricular failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Drug Therapy, Combination; Heart Failure; Hemodynamics; Hu | 1985 |
[Effect of peripheral vasodilators on the local contractile function of the myocardium in patients with post-infarction cardiosclerosis].
Topics: Aged; Captopril; Endomyocardial Fibrosis; Female; Humans; Male; Middle Aged; Myocardial Contraction; | 1988 |
[Prazosin pharmacodynamics and pharmacokinetics in patients with myocardial infarct complicated by heart failure in the subacute period].
Topics: Adult; Aged; Cardiac Catheterization; Drug Tolerance; Electrocardiography; Female; Half-Life; Heart | 1987 |